For patients and clinicians seeking guidance on currently approved weight management therapies in the UK, NICE has published relevant technology appraisals and guidelines, including: NICE TA875 semaglutide (Wegovy) for weight management in adults [9] NICE TA1026 tirzepatide (Mounjaro) for weight management (please verify the current TA number and scope at nice
No, muscle lost during GLP-1 therapy can be rebuilt through resistance training and proper nutrition, though prevention is significantly more efficient than regrowth
Variability arises from clinician decisions, pharmacy availability, and published program terms rather than user actions or timelines
In addition, multiple studies have demonstrated the efficacy of GLP-1 analogs in modifying eating behaviors
Foods to Skip Some foods can make side effects worse or interfere with results
Understanding why this happens and when to seek advice is essential for protecting your reproductive health